Thank You, NCPA 2026! It was great connecting with our customers and industry partners.
YARAL Pharma is bringing a little something different to the 2026 National Community Pharmacists Association (NCPA) Annual Convention & Expo, October 3-6 in Kansas City, Missouri.
YARAL Pharma Brings Build-A-Bear Workshop® Experience to NCPA 2026 Read More »
This Guest Column appeared in Drug Store News | June 8, 2026 By Stephen Beckman, CEO.
Reliable Supply, Real Impact: Doing Things Differently in Generics Read More »
A guiding philosophy shaping how the company operates, partners, and grows in the U.S. generics market
YARAL Pharma Reinforces Its Commitment to Doing Things Differently Read More »
Compact packaging helps simplify storage, ease inventory concerns, and make daily pharmacy operations more manageable
In this Drug Store News article several pharmaceutical company executives were asked about the greatest areas of opportunity, how their organizations are positioning to capitalize on them and what changes they believe are necessary to build a more resilient, patient-focused generics ecosystem.
In this industry-focused, conversational interview, Pharmacy Podcast Network Host Todd Eury speaks with Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s commitment to continuity of supply, how consistent on-time delivery supports pharmacy operations, and the company’s philosophy of “Doing Things Differently” — redefining what it means to be a trusted generics partner.
Collaboration expands patient access to the Company’s prescription treatments through online telehealth consultations.
(NAPS)—An estimated 20 million Americans have some form of thyroid disease.1 During January, recognized as Thyroid Awareness Month, YARAL Pharma is raising awareness of thyroid disease, particularly hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. Despite its prevalence, thyroid disease remains widely misunderstood, with many people unaware of its
RxInsider has long been a trusted resource for pharmacy professionals—educating pharmacy management and market professionals on the products, services, and trends that impact pharmacy operations across the supply chain. At YARAL Pharma, supporting pharmacy and pharmacists is central to how we do business—from building a reliable, high-quality generics portfolio to partnering closely with customers to
The 20Ways Winter Retail issue of RxInsider is live! Read More »
This Article appeared in DSN | December 3, 2025 Read complete article on Drug Store News Generic and biosimilar medicines created $467 billion in savings for patients and the overall healthcare system in 2024, according to The Association for Accessible Medicines’ 2024 U.S. Generic & Biosimilar Medicines Saving Report. The report also noted that generics and
